The report noted that the clearest benefit of SPK was the protection of the 2 Pancreas Transplantation to Restore Glucose Control: Review of Clinical and Economic Evidence kidney from diabetes-related deterioration, but it drainage.4 Some researchers note that kidney- may also double the risk for kidney-rejection rejection episodes may double as a result of episodes. [...] This may limit the credibility of and 2000, the authors of this systematic review the included research because there is a potential report that a patient’s overall risk of death after for the introduction of unchecked bias. [...] One with the patients on the wait list, the overall limitation of interpreting the study’s results is PTA survival does not differ, PAK the fact that there was no explanation of why the transplantation patients have significantly worse matched control patients were not selected for overall survival, and SPK transplant patients transplantation. [...] When the charges to The lowest gains in life expectancy and QALY Medicare are considered, a SPK has compared with dialysis were in the DKT group significantly more charges than a KA at one and and the most gains were seen in the LKT group. [...] Details about the In the UK, the National Specialist Commissioning eligibility criteria for pancreas transplantation and Advisory Group stated that it funds the cost of the the amount of immunosuppressant therapy covered SPK of citizens of England (not citizens of Wales by each plan appear in each of the cited references.